nilutamide has been researched along with Metastase in 10 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thirty-six men with disseminated prostatic cancer and elevated plasma levels of prostatic acid phosphatase were randomly assigned to two groups." | 2.66 | Prevention of the transient adverse effects of a gonadotropin-releasing hormone analogue (buserelin) in metastatic prostatic carcinoma by administration of an antiandrogen (nilutamide). ( Billebaud, T; Costa, P; Dahan, R; Fiet, J; Grise, P; Husson, JM; Kuhn, JM; Louis, JF; Moulonguet, A; Navratil, H, 1989) |
| " Nausea and vomiting were the most common adverse events reported in Nilutamide group." | 2.61 | Efficacy and Safety of Nilutamide in Patients with Metastatic Prostate Cancer who Underwent Orchiectomy: A Systematic Review and Metaanalysis. ( Chhabra, M; Rashid, M; Shamshavali, K, 2019) |
| "The hormonal treatment of the prostate cancer grew rich of new therapeutic classes which are going to change the medical care of the prostate cancer in the coming years and the urologist must play its full part." | 2.49 | [Hormonal treatment in prostate cancer]. ( Bastide, C; Bruyère, F; Guy, L; Karsenty, G; Rozet, F, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (30.00) | 18.7374 |
| 1990's | 5 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rashid, M | 1 |
| Shamshavali, K | 1 |
| Chhabra, M | 1 |
| Bastide, C | 1 |
| Bruyère, F | 1 |
| Karsenty, G | 1 |
| Guy, L | 1 |
| Rozet, F | 1 |
| Matzkin, H | 1 |
| Braf, Z | 1 |
| Janknegt, RA | 1 |
| Fiet, J | 2 |
| Doré, JC | 1 |
| Gô, AL | 1 |
| Ojasoo, T | 1 |
| Raynaud, JP | 1 |
| Abbou, CC | 1 |
| Lucas, C | 1 |
| Leblanc, V | 1 |
| Kuhn, JM | 1 |
| Billebaud, T | 1 |
| Navratil, H | 1 |
| Moulonguet, A | 1 |
| Grise, P | 1 |
| Louis, JF | 1 |
| Costa, P | 1 |
| Husson, JM | 1 |
| Dahan, R | 1 |
| Knönagel, H | 1 |
| Bolle, JF | 1 |
| Hering, F | 1 |
| Senn, E | 1 |
| Hodel, T | 1 |
| Neuenschwander, H | 1 |
| Biedermann, C | 1 |
| Béland, G | 1 |
| Elhilali, M | 1 |
| Fradet, Y | 1 |
| Laroche, B | 1 |
| Ramsey, EW | 1 |
| Trachtenberg, J | 1 |
| Venner, PM | 1 |
3 reviews available for nilutamide and Metastase
| Article | Year |
|---|---|
Efficacy and Safety of Nilutamide in Patients with Metastatic Prostate Cancer who Underwent Orchiectomy: A Systematic Review and Metaanalysis.
Topics: Antineoplastic Agents; Disease Progression; Disease-Free Survival; Humans; Imidazolidines; Male; Neo | 2019 |
[Hormonal treatment in prostate cancer].
Topics: Androgen Antagonists; Androgen Receptor Antagonists; Antineoplastic Agents, Hormonal; Benzamides; Co | 2013 |
[Complete androgen blockage in the treatment of metastatic prostate cancer].
Topics: Androgen Antagonists; Antineoplastic Agents; Humans; Imidazoles; Imidazolidines; Male; Neoplasm Meta | 1994 |
7 trials available for nilutamide and Metastase
| Article | Year |
|---|---|
Total androgen blockade with the use of orchiectomy and nilutamide (Anandron) or placebo as treatment of metastatic prostate cancer. Anandron International Study Group.
Topics: Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents; Combined Modality Thera | 1993 |
Multivariate analysis of plasma hormones in patients with metastatic prostate cancer receiving combined LHRH-analog and antiandrogen therapy.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Bioma | 1993 |
[Tolerance and clinical and biological responses during the first 6 months of treatment with 1-month sustained release LHRH agonists leuprolerin and triptolerin in patients with metastatic prostate cancer].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents; Antineoplastic | 1997 |
A comparison of the treatment of metastatic prostate cancer by testicular ablation or total androgen blockade. The Canadian Anandron Study Group.
Topics: Adult; Aged; Androgen Antagonists; Antineoplastic Agents; Humans; Imidazoles; Imidazolidines; Male; | 1992 |
Prevention of the transient adverse effects of a gonadotropin-releasing hormone analogue (buserelin) in metastatic prostatic carcinoma by administration of an antiandrogen (nilutamide).
Topics: Acid Phosphatase; Aged; Androgen Antagonists; Buserelin; Drug Evaluation; Humans; Imidazoles; Imidaz | 1989 |
[Therapy of metastatic prostatic cancer by orchiectomy plus Anandron versus orchiectomy plus placebo. Initial results of a randomized multicenter study].
Topics: Aged; Androgen Antagonists; Combined Modality Therapy; Double-Blind Method; Humans; Imidazoles; Imid | 1989 |
Total androgen blockade for metastatic cancer of the prostate.
Topics: Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Combined Modality T | 1988 |